These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32256730)

  • 1. Triamcinolone acetonide combined with aminoguanidine inhibits inflammation and oxidative stress, improves vascular endothelial and retinal function and reduces VEGF expression in diabetic retinopathy patients.
    Xu K; Qian H; Zou M
    Exp Ther Med; 2020 Apr; 19(4):2519-2526. PubMed ID: 32256730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamcinolone Acetonide Suppresses Inflammation and Facilitates Vascular Barrier Function in Human Retinal Microvascular Endothelial Cells.
    Imai S; Otsuka T; Naito A; Shimazawa M; Hara H
    Curr Neurovasc Res; 2017; 14(3):232-241. PubMed ID: 28625129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of laser photocoagulation plus ranibizumab in patients with diabetic retinopathy and their effect on VEGF.
    Zhou X; Yu G; Yao L
    Am J Transl Res; 2023; 15(1):193-201. PubMed ID: 36777841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effects of ursolic acid on diabetic retinopathy in mice].
    Sun Y; Sun X; Wang F; Liu S
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2589-93. PubMed ID: 26711605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.
    Tatar O; Adam A; Shinoda K; Kaiserling E; Boeyden V; Claes C; Eckardt C; Eckert T; Pertile G; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; Grisanti S
    Arch Ophthalmol; 2009 Mar; 127(3):275-81. PubMed ID: 19273790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of triamcinolone acetonide on retinal inflammation and angiogenesis induced by pericyte depletion in mouse.
    Otsuka T; Masuda T; Takahashi Y; Suzuki A; Uemura A; Arakawa R; Okabe T; Naito A
    J Pharmacol Sci; 2023 Jan; 151(1):28-36. PubMed ID: 36522120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
    Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
    Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
    Sohn HJ; Han DH; Lee DY; Nam DH
    Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits.
    Arimura S; Takamura Y; Miyake S; Gozawa M; Iwasaki K; Tomomatsu T; Matsumura T; Inatani M
    Exp Eye Res; 2016 Aug; 149():1-7. PubMed ID: 27296072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakage.
    Kim YH; Choi MY; Kim YS; Park CH; Lee JH; Chung IY; Yoo JM; Choi WS; Cho GJ; Kang SS
    Life Sci; 2007 Sep; 81(14):1167-73. PubMed ID: 17881007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
    Koleva-Georgieva DN; Sivkova NP; Terzieva D
    Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of the Chinese herbal medicine prescription Zhujing pill on retina of streptozotocin-induced diabetic rats.
    Lei X; He J; Ren C; Zhou Y; Chen X; Dou J
    Biomed Pharmacother; 2018 Feb; 98():643-650. PubMed ID: 29289839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
    Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
    Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.